Meta-analysis
Open access
Sep 2026
Overall survival with immune checkpoint inhibitors across treatment settings and clinical and PD-L1-defined subgroups in advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of randomized trials
ICI-containing regimens improved overall survival in both first- and later-line settings, but aggregate within-trial interaction analyses did not identify a reliable clinical or PD-L1-defined treatment-effect modifier.
Bing Wang, Xiao-Yu Han, Zeng-Li Shen
· Frontiers in Immunology · 0 citations